Global Respiratory Disease Testing Market Research Report 2021
Table of Contents1 Respiratory Disease Testing Market Overview
1.1 Product Overview and Scope of Respiratory Disease Testing
1.2 Respiratory Disease Testing Segment by Type
1.2.1 Global Respiratory Disease Testing Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Imaging Test
1.2.3 Respiratory Measurement
1.2.4 Blood Gas Test
1.2.5 Other
1.3 Respiratory Disease Testing Segment by Application
1.3.1 Respiratory Disease Testing Sales Comparison by Application: (2021-2027)
1.3.2 Hospitals
1.3.3 Physician Clinics
1.3.4 Clinical Laboratories
1.3.5 Others
1.4 Global Respiratory Disease Testing Market Size Estimates and Forecasts
1.4.1 Global Respiratory Disease Testing Revenue 2016-2027
1.4.2 Global Respiratory Disease Testing Sales 2016-2027
1.4.3 Respiratory Disease Testing Market Size by Region: 2016 Versus 2021 Versus 2027
2 Respiratory Disease Testing Market Competition by Manufacturers
2.1 Global Respiratory Disease Testing Sales Market Share by Manufacturers (2016-2021)
2.2 Global Respiratory Disease Testing Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Respiratory Disease Testing Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Respiratory Disease Testing Manufacturing Sites, Area Served, Product Type
2.5 Respiratory Disease Testing Market Competitive Situation and Trends
2.5.1 Respiratory Disease Testing Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Respiratory Disease Testing Players Market Share by Revenue
2.5.3 Global Respiratory Disease Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Respiratory Disease Testing Retrospective Market Scenario by Region
3.1 Global Respiratory Disease Testing Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Respiratory Disease Testing Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Respiratory Disease Testing Market Facts & Figures by Country
3.3.1 North America Respiratory Disease Testing Sales by Country
3.3.2 North America Respiratory Disease Testing Revenue by Country
3.3.3 United States
3.3.4 Canada
3.3.3 Mexico
3.4 Europe Respiratory Disease Testing Market Facts & Figures by Country
3.4.1 Europe Respiratory Disease Testing Sales by Country
3.4.2 Europe Respiratory Disease Testing Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 UK
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Respiratory Disease Testing Market Facts & Figures by Region
3.5.1 Asia Pacific Respiratory Disease Testing Sales by Region
3.5.2 Asia Pacific Respiratory Disease Testing Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Indonesia
3.5.9 Thailand
3.5.10 Malaysia
3.5.11 Philippines
3.5.12 Vietnam
3.6 Latin America Respiratory Disease Testing Market Facts & Figures by Country
3.6.1 Latin America Respiratory Disease Testing Sales by Country
3.6.2 Latin America Respiratory Disease Testing Revenue by Country
3.6.3 Brazil
3.7 Middle East and Africa Respiratory Disease Testing Market Facts & Figures by Country
3.7.1 Middle East and Africa Respiratory Disease Testing Sales by Country
3.7.2 Middle East and Africa Respiratory Disease Testing Revenue by Country
3.7.3 Turkey
3.7.4 GCC Countries
3.7.5 Egypt
3.7.6 South Africa
4 Global Respiratory Disease Testing Historic Market Analysis by Type
4.1 Global Respiratory Disease Testing Sales Market Share by Type (2016-2021)
4.2 Global Respiratory Disease Testing Revenue Market Share by Type (2016-2021)
4.3 Global Respiratory Disease Testing Price by Type (2016-2021)
5 Global Respiratory Disease Testing Historic Market Analysis by Application
5.1 Global Respiratory Disease Testing Sales Market Share by Application (2016-2021)
5.2 Global Respiratory Disease Testing Revenue Market Share by Application (2016-2021)
5.3 Global Respiratory Disease Testing Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Fischer & Paykel
6.1.1 Fischer & Paykel Corporation Information
6.1.2 Fischer & Paykel Description and Business Overview
6.1.3 Fischer & Paykel Respiratory Disease Testing Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Fischer & Paykel Product Portfolio
6.1.5 Fischer & Paykel Recent Developments/Updates
6.2 Medtronic
6.2.1 Medtronic Corporation Information
6.2.2 Medtronic Description and Business Overview
6.2.3 Medtronic Respiratory Disease Testing Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Medtronic Product Portfolio
6.2.5 Medtronic Recent Developments/Updates
6.3 MGC Diagnostics Corporation
6.3.1 MGC Diagnostics Corporation Corporation Information
6.3.2 MGC Diagnostics Corporation Description and Business Overview
6.3.3 MGC Diagnostics Corporation Respiratory Disease Testing Sales, Revenue and Gross Margin (2016-2021)
6.3.4 MGC Diagnostics Corporation Product Portfolio
6.3.5 MGC Diagnostics Corporation Recent Developments/Updates
6.4 CAREstream Medical Ltd.
6.4.1 CAREstream Medical Ltd. Corporation Information
6.4.2 CAREstream Medical Ltd. Description and Business Overview
6.4.3 CAREstream Medical Ltd. Respiratory Disease Testing Sales, Revenue and Gross Margin (2016-2021)
6.4.4 CAREstream Medical Ltd. Product Portfolio
6.4.5 CAREstream Medical Ltd. Recent Developments/Updates
6.5 Becton Dickinson (Carefusion Corporation)
6.5.1 Becton Dickinson (Carefusion Corporation) Corporation Information
6.5.2 Becton Dickinson (Carefusion Corporation) Description and Business Overview
6.5.3 Becton Dickinson (Carefusion Corporation) Respiratory Disease Testing Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Becton Dickinson (Carefusion Corporation) Product Portfolio
6.5.5 Becton Dickinson (Carefusion Corporation) Recent Developments/Updates
6.6 Koninklijke Philips N.V. (Respironics)
6.6.1 Koninklijke Philips N.V. (Respironics) Corporation Information
6.6.2 Koninklijke Philips N.V. (Respironics) Description and Business Overview
6.6.3 Koninklijke Philips N.V. (Respironics) Respiratory Disease Testing Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Koninklijke Philips N.V. (Respironics) Product Portfolio
6.6.5 Koninklijke Philips N.V. (Respironics) Recent Developments/Updates
6.7 ResMed Company
6.6.1 ResMed Company Corporation Information
6.6.2 ResMed Company Description and Business Overview
6.6.3 ResMed Company Respiratory Disease Testing Sales, Revenue and Gross Margin (2016-2021)
6.4.4 ResMed Company Product Portfolio
6.7.5 ResMed Company Recent Developments/Updates
7 Respiratory Disease Testing Manufacturing Cost Analysis
7.1 Respiratory Disease Testing Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Respiratory Disease Testing
7.4 Respiratory Disease Testing Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Respiratory Disease Testing Distributors List
8.3 Respiratory Disease Testing Customers
9 Respiratory Disease Testing Market Dynamics
9.1 Respiratory Disease Testing Industry Trends
9.2 Respiratory Disease Testing Growth Drivers
9.3 Respiratory Disease Testing Market Challenges
9.4 Respiratory Disease Testing Market Restraints
10 Global Market Forecast
10.1 Respiratory Disease Testing Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Respiratory Disease Testing by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Respiratory Disease Testing by Type (2022-2027)
10.2 Respiratory Disease Testing Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Respiratory Disease Testing by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Respiratory Disease Testing by Application (2022-2027)
10.3 Respiratory Disease Testing Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Respiratory Disease Testing by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Respiratory Disease Testing by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of TablesTable 1. Global Respiratory Disease Testing Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Respiratory Disease Testing Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Respiratory Disease Testing Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Respiratory Disease Testing Covered in This Study
Table 5. Global Respiratory Disease Testing Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Respiratory Disease Testing Sales Share by Manufacturers (2016-2021)
Table 7. Global Respiratory Disease Testing Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Respiratory Disease Testing Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Respiratory Disease Testing Average Price (USD/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Respiratory Disease Testing Manufacturing Sites and Area Served
Table 11. Manufacturers Respiratory Disease Testing Product Type
Table 12. Global Respiratory Disease Testing Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Respiratory Disease Testing by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Respiratory Disease Testing as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Respiratory Disease Testing Sales by Region (2016-2021) & (K Units)
Table 16. Global Respiratory Disease Testing Sales Market Share by Region (2016-2021)
Table 17. Global Respiratory Disease Testing Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Respiratory Disease Testing Sales by Country (2016-2021) & (K Units)
Table 19. North America Respiratory Disease Testing Sales Market Share by Country (2016-2021)
Table 20. North America Respiratory Disease Testing Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Respiratory Disease Testing Revenue Market Share by Country (2016-2021)
Table 22. Europe Respiratory Disease Testing Sales by Country (2016-2021) & (K Units)
Table 23. Europe Respiratory Disease Testing Sales Market Share by Country (2016-2021)
Table 24. Europe Respiratory Disease Testing Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Respiratory Disease Testing Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Respiratory Disease Testing Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Respiratory Disease Testing Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Respiratory Disease Testing Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Respiratory Disease Testing Revenue Market Share by Region (2016-2021)
Table 30. Latin America Respiratory Disease Testing Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Respiratory Disease Testing Sales Market Share by Country (2016-2021)
Table 32. Latin America Respiratory Disease Testing Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Respiratory Disease Testing Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Respiratory Disease Testing Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Respiratory Disease Testing Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Respiratory Disease Testing Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Respiratory Disease Testing Revenue Market Share by Country (2016-2021)
Table 38. Global Respiratory Disease Testing Sales (K Units) by Type (2016-2021)
Table 39. Global Respiratory Disease Testing Sales Market Share by Type (2016-2021)
Table 40. Global Respiratory Disease Testing Revenue (Million US$) by Type (2016-2021)
Table 41. Global Respiratory Disease Testing Revenue Share by Type (2016-2021)
Table 42. Global Respiratory Disease Testing Price (USD/Unit) by Type (2016-2021)
Table 43. Global Respiratory Disease Testing Sales (K Units) by Application (2016-2021)
Table 44. Global Respiratory Disease Testing Sales Market Share by Application (2016-2021)
Table 45. Global Respiratory Disease Testing Revenue (Million US$) by Application (2016-2021)
Table 46. Global Respiratory Disease Testing Revenue Share by Application (2016-2021)
Table 47. Global Respiratory Disease Testing Price (USD/Unit) by Application (2016-2021)
Table 48. Fischer & Paykel Corporation Information
Table 49. Fischer & Paykel Description and Business Overview
Table 50. Fischer & Paykel Respiratory Disease Testing Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 51. Fischer & Paykel Respiratory Disease Testing Product
Table 52. Fischer & Paykel Recent Developments/Updates
Table 53. Medtronic Corporation Information
Table 54. Medtronic Description and Business Overview
Table 55. Medtronic Respiratory Disease Testing Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 56. Medtronic Respiratory Disease Testing Product
Table 57. Medtronic Recent Developments/Updates
Table 58. MGC Diagnostics Corporation Corporation Information
Table 59. MGC Diagnostics Corporation Description and Business Overview
Table 60. MGC Diagnostics Corporation Respiratory Disease Testing Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 61. MGC Diagnostics Corporation Respiratory Disease Testing Product
Table 62. MGC Diagnostics Corporation Recent Developments/Updates
Table 63. CAREstream Medical Ltd. Corporation Information
Table 64. CAREstream Medical Ltd. Description and Business Overview
Table 65. CAREstream Medical Ltd. Respiratory Disease Testing Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 66. CAREstream Medical Ltd. Respiratory Disease Testing Product
Table 67. CAREstream Medical Ltd. Recent Developments/Updates
Table 68. Becton Dickinson (Carefusion Corporation) Corporation Information
Table 69. Becton Dickinson (Carefusion Corporation) Description and Business Overview
Table 70. Becton Dickinson (Carefusion Corporation) Respiratory Disease Testing Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 71. Becton Dickinson (Carefusion Corporation) Respiratory Disease Testing Product
Table 72. Becton Dickinson (Carefusion Corporation) Recent Developments/Updates
Table 73. Koninklijke Philips N.V. (Respironics) Corporation Information
Table 74. Koninklijke Philips N.V. (Respironics) Description and Business Overview
Table 75. Koninklijke Philips N.V. (Respironics) Respiratory Disease Testing Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 76. Koninklijke Philips N.V. (Respironics) Respiratory Disease Testing Product
Table 77. Koninklijke Philips N.V. (Respironics) Recent Developments/Updates
Table 78. ResMed Company Corporation Information
Table 79. ResMed Company Description and Business Overview
Table 80. ResMed Company Respiratory Disease Testing Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 81. ResMed Company Respiratory Disease Testing Product
Table 82. ResMed Company Recent Developments/Updates
Table 83. Production Base and Market Concentration Rate of Raw Material
Table 84. Key Suppliers of Raw Materials
Table 85. Respiratory Disease Testing Distributors List
Table 86. Respiratory Disease Testing Customers List
Table 87. Respiratory Disease Testing Market Trends
Table 88. Respiratory Disease Testing Growth Drivers
Table 89. Respiratory Disease Testing Market Restraints
Table 90. Global Respiratory Disease Testing Sales Forecast by Type (2022-2027) & (K Units)
Table 91. Global Respiratory Disease Testing Sales Market Share Forecast by Type (2022-2027)
Table 92. Global Respiratory Disease Testing Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 93. Global Respiratory Disease Testing Revenue Market Share Forecast by Type (2022-2027)
Table 94. Global Respiratory Disease Testing Sales Forecast by Application (2022-2027) & (K Units)
Table 95. Global Respiratory Disease Testing Sales Market Share Forecast by Application (2022-2027)
Table 96. Global Respiratory Disease Testing Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 97. Global Respiratory Disease Testing Revenue Market Share Forecast by Application (2022-2027)
Table 98. Global Respiratory Disease Testing Sales Forecast by Region (2022-2027) & (K Units)
Table 99. Global Respiratory Disease Testing Sales Market Share Forecast by Region (2022-2027)
Table 100. Global Respiratory Disease Testing Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 101. Global Respiratory Disease Testing Revenue Market Share Forecast by Region (2022-2027)
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of FiguresFigure 1. Product Picture of Respiratory Disease Testing
Figure 2. Global Respiratory Disease Testing Market Share by Type in 2020 & 2027
Figure 3. Imaging Test Product Picture
Figure 4. Respiratory Measurement Product Picture
Figure 5. Blood Gas Test Product Picture
Figure 6. Other Product Picture
Figure 7. Global Respiratory Disease Testing Market Share by Application in 2020 & 2027
Figure 8. Hospitals
Figure 9. Physician Clinics
Figure 10. Clinical Laboratories
Figure 11. Others
Figure 12. Global Respiratory Disease Testing Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Respiratory Disease Testing Market Size 2016-2027 (US$ Million)
Figure 14. Global Respiratory Disease Testing Sales 2016-2027 (K Units)
Figure 15. Global Respiratory Disease Testing Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 16. Respiratory Disease Testing Sales Share by Manufacturers in 2020
Figure 17. Global Respiratory Disease Testing Revenue Share by Manufacturers in 2020
Figure 18. The Global 5 and 10 Largest Respiratory Disease Testing Players: Market Share by Revenue in 2020
Figure 19. Respiratory Disease Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 20. Global Respiratory Disease Testing Sales Market Share by Region (2016-2021)
Figure 21. Global Respiratory Disease Testing Sales Market Share by Region in 2020
Figure 22. Global Respiratory Disease Testing Revenue Market Share by Region (2016-2021)
Figure 23. Global Respiratory Disease Testing Revenue Market Share by Region in 2020
Figure 24. United States Respiratory Disease Testing Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Canada Respiratory Disease Testing Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Mexico Respiratory Disease Testing Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Germany Respiratory Disease Testing Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. France Respiratory Disease Testing Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. UK Respiratory Disease Testing Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Italy Respiratory Disease Testing Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Russia Respiratory Disease Testing Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. China Respiratory Disease Testing Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Japan Respiratory Disease Testing Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. South Korea Respiratory Disease Testing Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. India Respiratory Disease Testing Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Australia Respiratory Disease Testing Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Indonesia Respiratory Disease Testing Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Thailand Respiratory Disease Testing Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Malaysia Respiratory Disease Testing Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Philippines Respiratory Disease Testing Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Vietnam Respiratory Disease Testing Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Brazil Respiratory Disease Testing Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Turkey Respiratory Disease Testing Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. GCC Countries Respiratory Disease Testing Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Egypt Respiratory Disease Testing Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. South Africa Respiratory Disease Testing Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Sales Market Share of Respiratory Disease Testing by Type (2016-2021)
Figure 48. Sales Market Share of Respiratory Disease Testing by Application (2016-2021)
Figure 49. Sales Market Share of Respiratory Disease Testing by Application in 2020
Figure 50. Revenue Share of Respiratory Disease Testing by Application (2016-2021)
Figure 51. Revenue Share of Respiratory Disease Testing by Application in 2020
Figure 52. Manufacturing Cost Structure of Respiratory Disease Testing
Figure 53. Manufacturing Process Analysis of Respiratory Disease Testing
Figure 54. Respiratory Disease Testing Industrial Chain Analysis
Figure 55. Channels of Distribution
Figure 56. Distributors Profiles
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed